FdaApplication
ANDA 216957
Identifiers
- fda_app_no: ANDA216957
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2023-03-10 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CLINDAMYCIN HYDROCHLORIDE | CLINDAMYCIN HYDROCHLORIDE | EQ 75MG BASE | CAPSULE;ORAL |
| CLINDAMYCIN HYDROCHLORIDE | CLINDAMYCIN HYDROCHLORIDE | EQ 150MG BASE | CAPSULE;ORAL |
| CLINDAMYCIN HYDROCHLORIDE | CLINDAMYCIN HYDROCHLORIDE | EQ 300MG BASE | CAPSULE;ORAL |
3 products